← All trials
NCT01677936
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2012
- Primary completion
- Dec 31, 2013
- Completion date
- Jan 31, 2014
- First posted
- Sep 3, 2012
- Last posted
- Apr 23, 2014
- Enrollment
- 51
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- L-Marc Research CenterLead sponsor
- California Raisin Marketing BoardCollaborator
- L-Marc Research CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.